APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,901 | -57.1% | 6,622 | +2.6% | 0.02% | -56.6% |
| Q2 2023 | $587,777 | -57.5% | 6,452 | -69.2% | 0.05% | -61.0% |
| Q1 2023 | $1,383,445 | +43.1% | 20,974 | +12.2% | 0.14% | +36.0% |
| Q4 2022 | $966,512 | -25.8% | 18,691 | -1.9% | 0.10% | -24.8% |
| Q3 2022 | $1,302,000 | +72.0% | 19,058 | +13.9% | 0.13% | +75.0% |
| Q2 2022 | $757,000 | -10.2% | 16,739 | +0.9% | 0.08% | +5.6% |
| Q1 2022 | $843,000 | +8.2% | 16,583 | +0.7% | 0.07% | +14.3% |
| Q4 2021 | $779,000 | +45.6% | 16,473 | +1.5% | 0.06% | +31.2% |
| Q3 2021 | $535,000 | -62.2% | 16,228 | -27.5% | 0.05% | -63.1% |
| Q2 2021 | $1,414,000 | +47.8% | 22,378 | +0.4% | 0.13% | +38.3% |
| Q1 2021 | $957,000 | – | 22,299 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |